Although studies have examined the associations of either leptin or adiponectin with OSA, there are few studies [21–23] that have evaluated the simultaneous use of these adipokines in patients with OSA given their diametrically opposite metabolic effects. This evidence concerns the gene LEP and obstructive sleep apnea syndrome.